Titan Pharmaceuticals (TTNP) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Titan Pharmaceuticals in September 2026.
Titan Pharmaceuticals, Inc. is a pharmaceutical company. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus, and Nalmefene Implant, which is for the prevention of relapse in OUD patients following detoxification from opioids Its product development programs are in non-clinical stages of development.
About This Stock
Titan Pharmaceuticals Inc
TTNP
Current Price
$4.80
Potential 12 Month Profit
N/A
Sector
N/A
Industry
N/A
Ticker
TTNP
Market Cap
$6.37M
Potential 12 Month Profit
N/A
Sector
N/A
Industry
N/A
Sixth Month Growth Performance
Stock Performance Snapshot
Financial Health
Titan Pharmaceuticals is showing strong cash flow and book value, indicating solid financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.